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A Roadmap to Reopening a Neurosurgical Practice in the Age of COVID-19
Randy S. D’Amico1, Griffin Baum1, Yafell Serulle1, Danilo Silva1, Michael L. Smith1,2, Rebecca A. Wallack1,
Jason A. Ellis1, Mitchell Levine1, Rafael Ortiz1, John A. Boockvar1, David J. Langer1

BACKGROUND: The
Coronavirus
disease
2019
(COVID-19) outbreak has left a lasting mark on medicine
globally.

-

METHODS: Here we outline the steps that the Lenox Hill
Hospital/Northwell Health Neurosurgery Department—
located within the epicenter of the pandemic in New York
City—is currently taking to recover our neurosurgical efforts in the age of COVID-19.

-

RESULTS: We outline measurable milestones to identify
the transition to the recovery period and hope these recommendations may serve as a framework for an effective
path forward.

-

CONCLUSIONS: We believe that recovery following the
COVID-19 pandemic offers unique opportunities to disrupt
and rebuild the historical patient and office experience as
we evolve with modern medicine in a posteCOVID-19
world.

-

Here we present a roadmap for departmental recovery of
neurosurgical efforts in the age of COVID-19. We outline steps
that the Lenox Hill Hospital/Northwell Health Neurosurgery
Department—located within the epicenter of the pandemic—is
currently taking as the pandemic is brought under control, with
the hope that this may serve as a framework for an effective path
forward. We outline measurable milestones to identify transition
and reopening of our practices based on international, federal,
state, and local recommendations, which continue to evolve.1,2
This is done with the understanding that times are changing
rapidly, and that our responses to the pandemic must remain
ﬂuid. The speciﬁc milestones and suggestions included in this
report are judgments based on our current understanding;
however, individual departmental values, regional constraints,
and the overall trajectory of this global pandemic must be
considered,
as
these
will
heavily
inﬂuence
the
recommendations. It is understood that this will take time, but
planning should begin now so that the infrastructure is in place
when the time of transition arrives. Importantly, recovery
following the COVID-19 pandemic offers a unique opportunity
to disrupt and rebuild the historical patient and ofﬁce experiences
as we evolve with modern medicine in a posteCOVID-19 world.
STAGE I: CONTROLLING THE SPREAD

INTRODUCTION

T

he Coronavirus disease 2019 (COVID-19) outbreak has left
an indelible mark on medicine globally. Recommendations regarding the initial handling of the pandemic have
been published by international, federal, state, and local governing bodies. Although these organizations have begun to consider
what recovery will look like, algorithms regarding recovering
surgical subspecialties from the COVID-19 pandemic remain to be
outlined.
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As of this writing, the COVID-19 pandemic is still growing in the
United States, and community transmission is occurring in almost
every state. In anticipation of hospital overcrowding with
COVID-19 patients, and to contain the COVID-19 spread, the
American College of Surgeons (ACS) has recommended that
surgeons delay elective surgeries.3 In an effort to control the
spread, most neurosurgery departments have adopted protocols
triaging their currently scheduled cases, cancelling nonurgent
elective surgeries and limiting their clinics or using telehealth
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visits to facilitate social distancing mandates while continuing to
treat patients.4 Face-to-face patient care is limited to wound care
and emergent ER evaluation only. Individual departments and
neurosurgical subspecialties have established algorithms and
recommendations for resource utilization and case triage during
this stage to curtail the spread of COVID-19.4-8 These measures are
anticipated to remain in place as transmission measurably slows
down and infrastructure is reestablished to safely manage care for
patients.

STAGE II: RECOVERY
Triggering the End of Stage I
Stage II involves reopening standard neurosurgical practice in a
carefully staged approached. This can occur once we are able to
safely diagnose, treat, and isolate COVID-19 cases and their contacts and we see a measurable decrease in the transmission of the
disease (RO <1). During Stage II, physical distancing measures
and limitations for those at heightened risk from COVID-19 will be
critical. Viral and antibody testing should become more widespread, and routine point-of-care diagnostics may be used in
ofﬁces. We suggest the following hospital system criteria as critical to initiating Stage II neurosurgical recovery:
-

A sustained reduction in COVID-19 cases is seen for at least
14 days (i.e., 1 incubation period).9

-

The associated hospital system is safely able to treat all patients
needing hospitalization without resorting to crisis standards.

-

Rapid point-of-care testing is widely available to all patients/
providers.

-

State approval is provided if necessary.

Any return to Stage I, including a second wave of COVID-19
infection necessitating a return to crisis standards, will require
national/regional and system-wide reevaluation to identify better
methods for safely diagnosing, treating, and isolating cases.

What Does STAGE II Look Like?
The ACS and Centers for Medicare & Medicaid Services (CMS)
recently published recommendations for resuming elective surgery
and nonemergent healthcare.1,2 In general, these recommendations
reﬂect a hospital system's ability to 1) understand the epidemiologic
effects and impact of COVID-19 within their region; 2) to be prepared to handle both resumption of “normal” hospital functions, as
well as a potential reversion back to Stage I; 3) to handle patientspeciﬁc issues, such as the ability to effectively communicate with
and deliver nonemergent care to patients; 4) and to ensure that
high-quality care can be delivered. These broad categories must be
considered regionally when planning the recovery of a department.
However, the speciﬁc goals of recovering/restructuring a
neurosurgical department in Stage II must reﬂect that department's mission. As an example, Table 1 summarizes the speciﬁc
goals of our department for posteCOVID-19 recovery. Each goal
is further outlined below.
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Relax Physical Distancing Measures and Reopen the Ofﬁces in a Careful
Fashion to Prevent a Return to Stage I. Once we have begun moving
away from the “controlling the spread” period, hospital leaders
will begin an incremental and gradual easing of physical
distancing measures to continue the control of COVID-19 transmission. There must be continual monitoring for any sustained
rise in new cases locally and of hospital resources in the event that
a system returns to a position where it cannot treat patients
requiring hospitalization without resorting to crisis management.
This is necessary to avoid a reversion back to Stage I.
Workﬂows ultimately will be department-speciﬁc. We have
focused our efforts on augmenting our efforts through technological solutions. This includes continued use of telehealth platforms or app-based technologies that facilitate access using and
maximizing remote synchronous and asynchronous communication and image transfer and offer the ability to continue to limit
ofﬁce visits. This is critical for our higher-risk patient population
or patients in home quarantine. In general, the guiding principle
during this time should remain “in-person as last resort.”10
Fortunately, the beneﬁts of telemedicine for both patients and
neurosurgeons have been explored with positive reviews.10-12
Greater utilization of telehealth platforms will 1) diminish travel
times and lost work time for patients; 2) limit PPE and resource
utilization in the ofﬁce; 3) limit exposures to patients, family
members, caretakers, and practitioners; 4) and increase the
catchment area of the neurosurgical department.10,11,13 One
proposed workﬂow is demonstrated in Figure 1.
In addition to standard operating necessities, such as veriﬁcation of the reason for an appointment, imaging submission and
conﬁrmation, and insurance veriﬁcation, all patients requesting
an appointment should be prescreened for factors that put them at
higher risk of contracting or transmitting COVID-19. Patients
should be advised to complete a telehealth consent form at this
time and be given adequate instruction to set up telemedicine
capabilities. In-person visits should be restricted to patients whose
physical examination is unclear or concerning, to patients who are
unable to or refuse to participate in telehealth visits, and for indepth discussions regarding planned procedures. Postoperative
appointments will be virtual if possible, with in-ofﬁce wound care
as necessary. Should point-of-care testing become available,
patients who wish to be seen in the ofﬁce may be tested in the
ofﬁce setting. In addition, if widespread serologic testing capable
of identifying immunity to COVID-19 became available, a
COVID-recovered group of people capable of returning to work
and serving in higher-risk roles could be identiﬁed within the
department.
Triage the Sickest or Most At-Risk Patients Awaiting Semiurgent or
Elective Surgery to Ensure Treatment in a Timely Manner in the Event
of Return to Stage I. Departmental multidisciplinary subspecialty
case conferences can be used to triage cases based on urgency
during Stage I and can be continued during Stage II as operating
rooms (ORs) become available for semielective and elective cases.
In addition to guidelines recommended by the ACS during Stage
I,3 individual departments and subspecialties have promulgated
recommendations for triage during these times.4,8 We believe
that recovery of semiurgent and elective surgery following
transition to Stage II should not necessarily be on a ﬁrst-come,
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Table 1. Goals of Stage II of Neurosurgical Recovery from
COVID-19
1. Relax physical distancing measures and reopen the offices in a careful
fashion to prevent return to Stage I.
2. Triage the sickest or most at-risk patients awaiting semiurgent or elective
surgery to ensure treatment in a timely manner in the event of return to Stage I.
3. Position the neurosurgery department to have priority access to OR
availability.
4. Restructure sophisticated educational experience for residents/students/
patients.
5. Reinvigorate research efforts.
6. Constant reassessment of the new normal in anticipation of transition to
Stage III.

ﬁrst-served basis. Neurosurgeons should consider published
subspecialty suggestions in addition to obtaining multidisciplinary
consensus to drive the growth of case volume in the recovery
period. This is critically important as the potential for a return to
stage I remains undeﬁned.
Given the high viral load in the upper airway of infected patients
and the risks identiﬁed during endoscopic endonasal procedures,

WITH LESS

ROADMAP TO COVID-19 RECOVERY

these should continue to be delayed unless emergent or until
preoperative COVID-19 testing can be performed.14
Spine surgeons, as well as device companies, are planning for
the imminent ramp-up of procedures to catch up on the
backlog of surgical cases due to the pandemic. Ambulatory care
centers, especially with overnight nursing options, and facilities
that can extend care for 1e2 postoperative days have been
proposed as feasible options, as these centers may be able to
accommodate a signiﬁcant majority of spinal care.15 This is
especially possible if minimally invasive techniques are used
when indicated.
All surgical patients will be required to undergo COVID-19
testing within 48 hours of surgery. This can be done in person
or using home testing companies capable of providing the test.
In regions where COVID-19 testing remains poorly available, all
patients should be screened with a questionnaire to assess
likelihood of active disease and previous exposure before surgery. Positive-screened patients should undergo testing when
available or undergo a 14-day preoperative quarantine. Each OR
day should have both a ﬁrst group of planned OR cases and a
second group of “standby” tested patients added to the schedule
in the event that a scheduled case is COVID-19epositive and
delayed. This will enable all usable OR time to be ﬁlled. All efforts should be made to defer surgery on COVID-19epositive

Figure 1. An example of a clinical workflow using telemedicine during the recovery from COVID-19.
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has been addressed in a patient-centered manner. Multidisciplinary consensus regarding the urgency of surgical cases can help
triage cases by medical need. We have adopted the scale shown in
Table 2 to assist with case prioritization.

Table 2. Case Prioritization Scale
Emergency procedures (priority 4)
-

Delay would cause immediate severe harm or death.

-

Delay would result in permanent disability or severe harm.

-

Patient is medically unstable related to a surgical condition.

Urgent procedures (priority 3)
-

Delay or further delay beyond 4 weeks risks significant patient harm.

-

Delay would prolong current hospital stay or increase the likelihood of
transmission during the pandemic.

-

Patients have failed medical management of a surgical condition.

Semiurgent procedures (priority 2)
-

Delay or further delay beyond 3 months risks patient harm.

-

Delay would increase the risk of a hospital stay or create the likelihood of
later hospital admission.

Nonurgent procedures (priority 1)
-

Delay or further delay beyond 6 months poses minor or no risks of patient harm.

Elective procedures (priority 0)
-

Timing of procedure does not affect clinical outcome

patients for at least 14 days. Enhanced PPE precautions should be
used in all cases, especially in light of the risk of false-negative
tests. In addition, separate COVID-19 and noneCOVID-19
environments should be maintained in the intensive care unit
and the OR.
Essential staff should be permitted in the OR. Given the risk of
aerosolization of the virus before and during intubation, all staff
nonessential to intubation should leave the room during intubation.16,17 In addition, we have incorporated a clear plastic
drape laid over the eyes, nose, and mouth of intubated patients
to limit aerosolization of viral particles during procedures.
Position the Neurosurgery Department to Have Priority Access to
Elective OR Availability. OR utilization and prioritization discussions no doubt have been underway at all hospitals during Stage I,
typically with tight restrictions to “emergent” patients with
impending loss of life, limb, or neurologic function. During Stage
II, surgical care will be progressively expanded to those patients
with nonemergent but “urgent” and “semiurgent” conditions,
representing severe and signiﬁcant conditions.
This prioritization may be best handled within the surgical
departments, led by department chairs and section chiefs, as
prioritization at the hospital level might not work well. The collective wisdom and experience of department faculty should
minimize conﬂict.
Preexisting OR block times and priority should be deprioritized
during Stage II until the backlog of urgent and semiurgent cases
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Restructure Sophisticated Educational Experiences for Residents/
Students/Patients. As restrictions on physical distancing are
relaxed, students and staff nonessential to clinical care will be
permitted to slowly return to work. Preventing a return to Stage
I remains critical to Stage II recovery, and resource utilization
will remain a signiﬁcant concern until we transition clearly out
of Stage II.
As a department, we will use this opportunity to restructure
and update our educational and patient information content. It
is likely that limited or no patient visitation will be permitted,
resulting in new stresses on inpatient staff. Mobile and desktop
telehealth, as well as “asynchronous” video and audio messages,
can be delivered to families utilizing newly designed apps. Large
group video conferencing permits sophisticated and safe
educational sessions. Adoption of virtual reality and augmented
reality education systems will increase educational content for
students, residents, and patients alike. Resident education will
proceed as usual as normal resident stafﬁng is resumed; however, every effort to utilize virtual conferencing and education
should continue to maintain social distancing efforts. Should
serologic testing become available, visiting students will be
required to be tested for immunity as well as COVID-19 to
protect patients and their communities.
Reinvigorate Research Efforts. Nonessential laboratory workers,
research track faculty, postdoctoral fellows, and graduate students will undergo screening for COVID-19 exposure and will be
permitted to return to work as physical distancing is relaxed. As
widespread serologic testing becomes available, demonstration
of immunity may be required. People at high risk will continue
to maintain physical distancing. Researchers will be encouraged
to continue working remotely whenever possible to mitigate the
spread of disease. Any U.S. Department of Agricultureecovered
animal facility will be permitted to continue basic animal care
and husbandry operations. Patients being enrolled into clinical
trials will be encouraged to use telehealth technologies and
established in-home lab services when able.
STAGE III: OUR NEW NORMAL
Stage III involves the lifting of all physical distancing recommendations and depends heavily on the development of effect
methods of prophylaxis and treatment. At the time of this writing,
it is hard to predict where Stage I will end, let alone how long
Stage II may last before transition to Stage III occurs. Importantly,
none of this is meant to function as dogma. We have currently
identiﬁed these goals with an explicit understanding that times
are changing rapidly, and that our responses to the pandemic
must remain ﬂuid. The speciﬁc milestones and suggestions
included in this report are judgments based on our current understanding, and, as we have seen, this can change rapidly.
Importantly, we believe that recovery following the COVID-19
pandemic offers a unique opportunity to disrupt and rebuild the
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historical patient and ofﬁce experiences in a modern poste
COVID-19 world.

doing what you were trained to do. It manifests not in those whose
training spared them hardship, but rather in those whose training
embraced hardship and taught them to deal with it.18

CONCLUSION
As neurosurgeons, we have always been at the technological
forefront of medicine. The recovery from COVID-19 will provide us
a unique opportunity to rebuild essentially from zero, with the
experience and knowledge to hit the ground running. We believe
this is not a time to rest on our laurels as neurosurgeons or do
things because we were taught to do them “the same way every
time.” Now is a time to innovate, anticipate, and embrace the
technologies and advancements that will enable us to safely
overcome this period of darkness and isolation. As a department,
we are tasked now not to just rebuild neurosurgery, but also to
ﬁnd new ways to expand it. Maintaining excellence is at the core of
our training; however, excellence is not an action—it is a habit.
Tenacity is not a spontaneous ﬂowering of good character—it is
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